Niels Bergemann

Niels Bergemann is an Honorary Professor at the University of Trier with clinical practice at Regena Private Clinic in Bad Brückenau. His academic work focuses on the intersection of psychiatry, pharmacology, and endocrinology, with particular expertise in therapeutic drug monitoring and psychopharmacology in special patient populations. He teaches courses on Fundamentals of Psychopharmacology and maintains active research collaborations across multiple institutions.

Professor Bergemann's research interests span Clinical Psychopharmacology, Psychoendocrinology, Therapeutic Drug Monitoring, Psychotropic Drugs in Pregnancy, Affective Disorders, Psychotraumatology, and Schizophrenia. His work particularly emphasizes the pharmacological management of psychiatric conditions in women, with special attention to pregnancy and hormonal influences on mental health. He has made significant contributions to understanding the interactions between psychotropic medications and hormonal systems, particularly in women with schizophrenia and affective disorders.

Analysis of his recent publications (2017-2025) reveals a strong focus on therapeutic drug monitoring guidelines, psychopharmacology in pregnancy, PTSD treatment, and schizophrenia management. His work demonstrates consistent expertise in translating pharmacological research into clinical practice guidelines, particularly through his involvement with consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology. A notable trend is his increasing focus on specialized patient populations, including pregnant women and trauma survivors.

Professor Bergemann has served as co-editor for several important publications including "Psychopharmacotherapy for Special Patient Groups" (2025, in press) and has contributed significantly to consensus guidelines in therapeutic drug monitoring. His work has influenced clinical practice through evidence-based recommendations for psychopharmacological treatment across various patient populations.